alexa Editor-in-Chief |Blood and lymph Journals
ISSN: 2165-7831

Journal of Blood & Lymph
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 
 
 
 
 
 

Editor-in-Chief

Guido J.K. Tricot Editor-in-Chief
Guido J.K. Tricot
Professor
Department of Medicine
University of Utah
School of Medicine
USA
 
Biography

Guido Tricot, MD, PhD, is the director of Huntsman Cancer Institutes Myeloma Program. He has been researching and treating multiple myeloma for over twenty years. Tricot is also a professor in the Department of Medicine at the University of Utah School of Medicine. His team treatment strategies are based on tandem autologous transplantation, a treatment approach that has increased the median survival rate of patients to ten years or more, compared to 2.5 to 3 years with conventional chemotherapy. The long-term outcome data of Dr. Tricots work have been published extensively. He has received several research grants from the National Cancer Institute and has been principal investigator on many myeloma clinical trials. Dr. Tricot regularly gives presentations on multiple myeloma all over the United States and the world. His research has appeared in numerous publications, including New England Journal of Medicine, the Lancet, the Journal of Clinical Oncology, Blood, Cancer Research, Clinical Cancer Research, the British Journal of Haematology, Seminars in Hematology, and Hematology/Oncology Clinics of North America. He is also a peer reviewer for many medical journals. He received his medical and doctoral degree at the University of Leuven in Belgium. Before joining Huntsman Cancer Institute, he was the Director of Clinical Research at the University of Arkansas Myeloma Institute for Research and Therapy, the largest myeloma program in the world. Dr. Tricot has also served as Director of Bone Marrow and Stem Cell Transplantation at the Greenebaum Cancer Center at the University of Maryland and at Indiana University.

 
Research Interest

His research has appeared in numerous publications, including New England Journal of Medicine, the Lancet, the Journal of Clinical Oncology, Blood, Cancer Research, Clinical Cancer Research, the British Journal of Haematology, Seminars in Hematology, and Hematology/Oncology Clinics of North America. He is also a peer reviewer for many medical journals.

 
Network
 
Susumu Ikehara Editor-in-Chief Susumu Ikehara
Professor
Department of Stem Cell Disorders
Kansai Medical University
Japan
 
 
Biography

Professor Susumu Ikehara received his M.D. in (1968) and his Ph.D. in 1977 degree (1977) from Kyoto University. He began his career in the Department of Pathology at Kyoto University in (1976), and was promoted to Professor of Pathology at Kansai Medical University (in 1986). He has served as Director of the Transplantation Center at Kansai Medical University since 1998, as well as Director of the Regeneration Research Center for Intractable Diseases since 2001, and finally as the Director for Cancer Therapy in since 2003 at Kansai Medical University. He has been a distinguished visiting investigator with Dr. Robert Good at Memorial Sloan Kettering Cancer Center in between 1978- and1981. Dr. Ikehara has received numerous awards.

 
Research Interest

Dr. Susuma Ikehara research interest lies in Bone marrow transplantation in autoimmunity and as well as in Pathology, Immunology, Hematology, Oncology, and Cancer.

 
Network
 
Arun K. Rishi Editor-in-Chief Arun K. Rishi
Professor
Department of Oncology and Internal Medicine
Wayne State University
USA
 
 
Biography

Dr. Arun K. Rishi was born in Meerut, India. After the initial college education in India, Dr. Rishi obtained a M.Sc. in Biochemistry from University College London, UK, and a Ph.D. in Molecular Biology from Imperial College of Science Technology and Medicine, London, UK. He subsequently trained as a post-doctoral fellow at MIT and the Brigham and Womens Hospital, Harvard University Medical School, Boston, USA, and later held faculty positions at the Pulmonary Center, Boston University, Boston, and University of Maryland Cancer Center, Baltimore, Maryland, USA. Dr. Rishi is currently a professor at the Karmanos Cancer Institute and the Oncology Department of the Wayne State University School of Medicine, Detroit, Michigan, USA.
 

 
Research Interest

Dr. Rishi’s research interests focus on studying pathways and molecular mechanisms regulating cell growth/survival and death/apoptosis in cancer cells. Dr. Rishi identified and characterized a novel, apoptosis inducing protein termed CARP-1/CCAR1 that regulates apoptosis induced by diverse agents including an apoptogenic retinoid CD437, Adriamycin, Etoposide, but not by chemotherapy agents such as Cisplatin. CARP-1 also regulates apoptosis by EGFRs and protein kinase A. CARP-1 is a phospho-protein that functions in part by interacting with multiple regulators of cell growth and apoptosis signaling. Data from biopsies of human breast cancers and Non-Hodgkin’s Lymphomas (NHL) suggest an inverse correlation of CARP-1 expression with the grades of the tumors, indicating a potential prognostic value and a tumor suppressor property of CARP-1. Our on-going studies are focused to further elucidate the molecular mechanisms of adriamycin and EGFRs signaling that target CARP-1 and CARP-1 interactions with regulators of cell growth and apoptosis. Our long-term goal is to exploit this knowledge for development of strategies to inhibit a variety of cancers including the drug-resistant cancers.
 

 
Network
 
 
 
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version